Lantheus Holdings Stock News

Charles Schwab Investment Management Inc. grew its holdings in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) by 2.6% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 467,014 shares of the medical equipment providers stock after buying an additional 12,012 shares during the quarter. Charles Schwab []

Zacks Investment Research cut shares of Lantheus (NASDAQ:LNTH) from a buy rating to a hold rating in a research report released on Saturday morning, Zacks.com reports. According to Zacks, “Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves […]

Lantheus (NASDAQ:LNTH) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a report issued on Saturday, Zacks.com reports. According to Zacks, Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, []

Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q3 2021 Results - Earnings Call Transcript

NORTH BILLERICA, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging diagno

NORTH BILLERICA, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on

NORTH BILLERICA, Mass. and HAYWARD, Calif., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus) and RefleXion Medical, Inc., today announced a development and commerci

Highlights Piflufolastat F 18's Potential to Change Initial Risk Assessment and Intended Patient Management in High-Risk Prostate Cancer

NORTH BILLERICA, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging diagn

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus) announced today that its subsidiary, EXINI Diagnostics AB, was granted 510(k) clearance by the U.S. Food and

Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q2 2021 Results - Earnings Call Transcript

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 120.00% and 6.83%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Shares of Lantheus Holdings (NASDAQ:LNTH) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 10.00% over the past year to $0.11, which beat the e

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 2

It has been nearly one year since I took a good look at Lantheus Holdings, but PYLARIFY's approval has forced me to reassess the ticker and my investment strategy. PYLARIFY has the potential to be a g